Structure Therapeutics Stock (NASDAQ: GPCR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 580.782K |
Day Range | - - - |
52 Wk Range | 21.790 - 75.017 |
Market Cap | $1.664B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 10.94% |
Days to Cover | 9.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Structure Therapeutics (NASDAQ: GPCR) through any online brokerage.
Other companies in Structure Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
The latest price target for Structure Therapeutics (NASDAQ: GPCR) was reported by JMP Securities on Friday, May 10, 2024. The analyst firm set a price target for 91.00 expecting GPCR to rise to within 12 months (a possible 154.90% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Structure Therapeutics (NASDAQ: GPCR) is $35.7 last updated May 14, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Structure Therapeutics.
Structure Therapeutics’s Q2 earnings are confirmed for Wednesday, August 14, 2024.
There is no upcoming split for Structure Therapeutics.
Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.